14-day Premium Trial Subscription Sign Up For FreeGet Free

Aethlon Medical Stock Forecast NASDAQ:AEMD

$1.72 (-0.58%)

Volume: 47k

Closed: Jan 19, 2022

Hollow Logo Score: -4.338

Aethlon Medical Stock Forecast

$1.72 (-0.58%)

Volume: 47k

Closed: Jan 19, 2022

Score Hollow Logo -4.338

Aethlon Medical Company Profile

9635 Granite Ridge Drive

San Diego CA 92123



Industry: Medical Devices

Sector: Healthcare

Aethlon Medical


Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in cancer, infectious diseases, and other life-threatening conditions in the United States. The company develops Aethlon Hemopurifier, a medical device, which targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Its Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. The company is also involved in developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. Aethlon Medical, Inc. was founded in 1991 and is based in San Diego, California.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE